Companies / Monopar Therapeutics Inc.

Monopar Therapeutics Inc.

Nasdaq: MNPRCIK 1645469WILMETTE, IL

Financials · FY2025

Revenue$0
Net income$-13.72M
Total debt—
Cash$52.76M
Diluted EPS—
Shares outstanding6.7M

Ownership

6.7M shares outstanding · as of Jul 31, 2026
3.0%Insiders
Ownership
Insiders2.97%199,259
Institutions83.17%5,582,436
Public float13.86%930,477

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 4

View all →
Insider% of sharesShares
Robinson ChandlerCEOChief Executive Officer · Director
2.21%148,533
Cittadine AndrewChief Operating Officer
0.76%50,726
Rioux Patrice—
——
Rodriguez SusanCCSO
——

Institutional holders 76

View all →
HolderValue% of shares
Janus Henderson Group PLC$72.06M19.63%
RA Capital Management, L.P.$36.56M9.94%
BlackRock, Inc.$32.30M5.20%
Saturn V Capital Management LP$21.27M4.85%
Vanguard Group Inc$19.19M4.38%
Deerfield Management Company, L.P.$17.74M4.82%
Adage Capital Partners Gp, L.L.C.$16.94M4.61%
ADAR1 Capital Management, LLC$15.27M3.48%
Wellington Management Group LLP$14.76M3.37%
Siren, L.L.C.$13.86M3.16%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Dec 31, 2025Robinson Chandler
CEO
OtherCommon Stock$167.0K-3K
-2.90%
85,718
1.28% of shares
low
Dec 31, 2025Cittadine Andrew
Executive
OtherCommon Stock$123.4K-2K
-3.59%
50,726
0.76% of shares
low
Jan 28, 2025Robinson Chandler
CEO
OtherCommon Stock$0+63K
62,815
0.94% of shares
low
Mar 2, 2026Rodriguez Susan
Executive
GrantStock Options—+49K
48,728
0.73% of shares
low
Dec 31, 2025Robinson Chandler
CEO
ExerciseRestricted Stock Unit—-9K
-7.17%
113,008
1.68% of shares
low
Dec 31, 2025Robinson Chandler
CEO
ExerciseCommon Stock—+9K
+10.97%
88,276
1.32% of shares
low
Dec 31, 2025Cittadine Andrew
Executive
ExerciseRestricted Stock Unit—-4K
-8.23%
48,267
0.72% of shares
low
Dec 31, 2025Cittadine Andrew
Executive
ExerciseCommon Stock—+4K
+8.96%
52,615
0.78% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
RA Capital Management, L.P.Passive13G/A———
AstraZeneca PLCPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
MNPRCommon StockEquity61023L207BBG00J7K8D90